| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.3B | $23.5B | $23.1B | $22.1B | $4.8B | $4.3B | $19.4B | $18.7B |
| Cost of Revenue | $15.4B | $15.0B | $14.8B | $14.4B | $12.2B | $10.9B | $13.1B | $12.8B |
| Gross Profit | $8.9B | $8.5B | $8.3B | $7.7B | $1.7B | $1.4B | $6.3B | $6.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $7.2B | $6.6B | $6.2B | $5.8B | $5.2B | $4.4B | $4.9B | $4.6B |
| Operating Income | — | — | — | — | — | — | — | $1.4B |
| Net Income | $0.1B | $0.9B | $1.3B | $1.2B | $0.3B | $0.2B | $0.6B | $0.8B |
| EPS (Basic) | $0.47 | $6.49 | $9.38 | $8.36 | $1.80 | $1.19 | $4.26 | $5.53 |
| EPS (Diluted) | $0.47 | $6.47 | $9.33 | $8.31 | $1.79 | $1.18 | $4.24 | $5.50 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.8B | $19.3B | $18.0B | $16.5B | $14.4B | $13.4B | $14.6B | $12.7B |
| Current Assets | $10.6B | $9.9B | $9.6B | $8.8B | $7.8B | $7.1B | $7.9B | $7.6B |
| Cash & Equivalents | — | — | — | — | — | — | — | $0.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $9.8B | $8.5B | $7.8B | $7.7B | $6.6B | $5.9B | $6.4B | $5.9B |
| Stockholders' Equity | $4.4B | $4.3B | $4.4B | $3.8B | $3.5B | $3.2B | $3.7B | $3.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $1.3B | $1.4B | — | — | — | $0.9B | $1.1B |
| Investing Cash Flow | $-0.7B | $-1.5B | $-0.7B | — | — | — | $-0.6B | $-0.5B |
| Capital Expenditures | $0.5B | $0.6B | $0.5B | $0.3B | $0.3B | $0.2B | $0.3B | $0.2B |
| Financing Cash Flow | $-0.2B | $-0.3B | $-0.3B | — | — | — | $-0.4B | $-0.6B |